Emergent Pharmaceutical Treatments for Dry Eye Diseases

In this interview, Marc R. Bloomenstein, OD, FAAO, and Mile Brujic, OD, FAAO, describe first-line treatments for patients with dry eye as well as strategies to address their inflammation and tips on educating these patients. You will learn how pharmaceutical management differs from mechanical management and the potential of new and emerging pharmaceutical treatments. Supported by unrestricted educational grants from Alcon, Bausch + Lomb, Johnson & Johnson Vision, RVL, Sight Sciences, Tarsus, Théa Pharma, and Trukera Medical.